chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Blotchy rash, itchy over all body, mostly on neck and face.  No respiratory problems.  Adviced to use Benadryl, however parents used some home remedies and the rash and swelling went away.  His eyes remained injected and his skin in the neck area was itchy the next day in the office. A follow up report received 10/22/2003 adds: Conjunctivitis treated with Benadryl/Tetanol eye drops.
Generalized hive plus itching at 12N. Mother gave BENADRYL OTC. - back to clinic 1:15p.m - pt less hives, advised increase fluid intake and give BENADRY more and observe for any worsening reaction to call 911 if needed or bring back to clinic.
This spontaneous report as received from a nurse and refers to an unspecified number of patients of unknown age and gender. There was no information about the patient's concurrent conditions, concomitant therapies or medical histories provided. On unknown dates, the patients were vaccinated with improperly stored doses of GARDASIL 9 lot # L038503, expiration date 18-DEC-2017 (dose and route of administration were not reported). There was no adverse effect reported. The vaccine underwent three separate temperature excursions. In the first excursion the vaccine was exposed to temperature between 0 to 2 degrees Celsius for 5 hours and 39 minutes. In the second temperature excursion the vaccine was exposed to temperature between 8 to 25 degrees Celsius for 1 hour and 15 minutes. In the third excursion the vaccine was exposed to temperature between 8 and 25 degrees Celsius for 14 hours and 57 minutes. Data logger was involved. No product quality complaint (PQC) was involved. Additional information has been requested.
We got our booster in January and husband was fine then on may11 got really dizzy and went to the hospital and never came back home he had over 15 strokes
Information was received on 27-JUN-2017 from a certified medical assistant regarding a 20 year old female patient who received one M-M-R II (lot# reported as M045395, expiration 14-NOV-2018) at a 0.5ml dose subcutaneously in her left arm with sterile diluent (lot# N007760, expiration 31-MAY-2018) on 22-JUN-2017 due to a titer drawn on an unknown date showing lack of immunity to mumps and varicella. The patient's medical history included that she was a health care worker with recent titer results showing lack of immunity to mumps and varicella. The medical assistant stated that the patient has no relevant laboratory data or concomitant medications. The medical assistant reported that on 27-JUN-2017, after an interview where the patient stated that she had not received M-M-R II, the patient was administered M-M-R II at a 0.5ml subcutaneous dose in her right arm. Upon a chart review later on in the day, medical assistant discovered that the patient had received this vaccine on 22-JUN-2017 as well. The medical assistant reported that the patient has not experienced an adverse reaction and therefore no treatments have been provided. The medical assistant stated that the patient received the same lot# and expiration dates of the vaccine and diluent on both administration dates. As of 27-JUN-2017, it was unknown if the patient will continue on M-M-R II and the outcome of receiving doses in a five day interval is unknown.  The is one of two cases concerning the same patient. Additional information has been requested.; Sender's Comments: US-009507513-1707USA001754:
This spontaneous report was received from a Licensed Practical Nurse regarding an unspecified number of patient of unknown demographics. There was no information about concurrent condition and historical medication. On an unknown date, the patient was vaccinated with improperly stored COMVAX lot # J013884 and expiration date 19-AUG-2016 (incorrect product storage). No concomitant medication was reported. No adverse event was reported. The outcome of the event was unknown. This is one of several reports received from the same reporter. Additional information has been requested.
I was not home and I  woke up and can't talk. I was coughing and Urgent Care said it was a sore throat. I pretty much was weak for 2 weeks, sleeping 11/12 hours a day and that's not me. I don't think it was the shot but I don't know. A couple days after I missed my plane because I couldn't move and the next day I went to my Doctor and referred me to an ENT.  For maybe a week I wasn't eating because my throat was almost closing.
I got a tetanus shot on Feb. 14th. My arm is very painful to the point it is hard to use. It wakes me up at night. I am taking Tylenol but it barely touches the pain
About 3 hours after the vaccine was given, I had chest pains and started running a fever. I had acute lower back pain and felt overall very lethargic. The fever continued  through the night and broke around 3am.  The next morning I felt okay but by 10am started to run a fever again for the remainder of the day and chest pains and headache/body aches were now VERY present.  It is now 5 days after the shot and I?m just starting to feel like myself again. The headaches and overall body aches lasted for days.  I also had blurry vision on and off during this time.  My husband and I workout every day and eat very well.  We?re not overweight and don?t smoke. The injection site is still sore 5 days later.   I will complete another form for my husband but he experienced the EXACT SAME reactions....every one of them.
after recv vax wed. pt starting feeling rotten, teething, thurs noc temp 104, now temp 103, vomiting, tired, shaky. 4/27, tues. felt fine.
Nerv pain same area when i had shingles; This case was reported by a consumer via call center representative and described the occurrence of post herpetic neuralgia in a 60-year-old patient who received Herpes zoster (Shingrix) for prophylaxis.   The patient's past medical history included shingles.   On an unknown date, the patient received Shingrix. On an unknown date, 10 days after receiving Shingrix, the patient experienced post herpetic neuralgia. On an unknown date, the outcome of the post herpetic neuralgia was recovering/resolving.   It was unknown if the reporter considered the post herpetic neuralgia to be related to Shingrix.     Additional Information: GSK receipt date: 30-NOV-2022 Reporter's comment:  The case was reported via interactive digital media. The patient asked could vaccine trigger post Shingles nerve pain. The patient received Shingrix vaccine and 10 days after vaccine patient experienced nerve pain in same areas when he/she had Shingles not as bad and it was resolving. No other information was provided.
Patient became dizzy and very pale in the waiting area post vaccine. 11:29AM layed patient down in cot with an ice pack. 11:36 Patients color returned in her face. B/P 99/58, pulse 67, O2 98% and patient states feeling better. 11:38 BP 100/57 Pulse 66, and O2 98. 11:42 Patient sitting position now, and denies dizziness. Drank some water. B/P 100/57. 11:50 Patient stood up and denies any complaints. Patient states she passed out as a young child after an injection. Patient had no food this morning before her appointment. Advised to eat and hydrate before next vaccine, and to lay down for injection.
No wheel noted on 1st attempt/ No wheel noted on 2nd attempt. Wheel achieved on 3rd attempt by another staff member
16NOV92 seen @ clinic for abscess on arm p/flu shot; pus has also drained; 2cm indurated abscess; Keflex; seen 23NOV92 for recheck-redness almost gone abscess lt arm resolving;
Fever x 4 days, indurated area of site of injection & inconsolable crying, getting better.
Pain in the right deltoid since injection. also with small lump.  parathesia intermittently radiating down to right elbow, with loss of strength to right arm.  Symptoms have persisted for 4 days.
uncomfortable while being administered the 2nd dose and after; Injection felt painful; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE DYSAESTHESIA (uncomfortable while being administered the 2nd dose and after) and VACCINATION SITE PAIN (Injection felt painful) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.   On an unknown date, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient experienced VACCINATION SITE DYSAESTHESIA (uncomfortable while being administered the 2nd dose and after) and VACCINATION SITE PAIN (Injection felt painful). At the time of the report, VACCINATION SITE DYSAESTHESIA (uncomfortable while being administered the 2nd dose and after) and VACCINATION SITE PAIN (Injection felt painful) outcome was unknown.            No relevant concomitant medications were reported. No treatment information was provided. Action taken with mRNA-1273 in response to the events was not applicable.   This case was linked to US-MODERNATX, INC.-MOD-2021-122933, US-MODERNATX, INC.-MOD-2021-123087 (E2B Linked Report).; Sender's Comments:  US-MODERNATX, INC.-MOD-2021-122933:wife US-MODERNATX, INC.-MOD-2021-123087:husband
AFTER PATIENT GOT THE VACCINE WHILE HE WAS WAITING FOR 15 MINUTES OBSERVATION HE WENT VERY PALE AND ALMOST FALLING, HIS WIFE WAS SUPPORTING HIM, WE CALLED 911 , PARAMEDICS CHECKED PATIENT OUT AND PATIENT FELT BETTER, REFUSED TO GO TO THE HOSPITAL, AFTER 20 MINUTES HE SAID HE WAS PRE-DIABETIC AND FELT BETTER THEN HE LEFT THE STORE.
Breakthrough case admission after 5 vaccines Pfizer 2/24/21 Lot# EN6200;  Pfizer 3/17/21 LOt# EN6207;  Pfizer 10/14/21 Lot# FF2587 ; Pfizer 7/20/22 Lot# FM0173  Pfizer 10/7/22 NO LOT #  LOT # IS NOT IN THE LOCAL STATE DATABASE;  DO NOT REQUEST
Blood clots; Kind of bleeding; arm began being extremely itchy; This spontaneous case was reported by a consumer and describes the occurrence of THROMBOSIS (Blood clots) and HAEMORRHAGE (Kind of bleeding) in a 40-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     The patient's past medical history included No adverse event (No reported medical history).    On 02-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 02-Apr-2021,  after starting mRNA-1273 (Moderna COVID-19 Vaccine), the patient experienced PRURITUS (arm began being extremely itchy). On 05-Apr-2021, the patient experienced THROMBOSIS (Blood clots) (seriousness criterion medically significant) and HAEMORRHAGE (Kind of bleeding) (seriousness criterion medically significant). At the time of the report, THROMBOSIS (Blood clots) and HAEMORRHAGE (Kind of bleeding) outcome was unknown and PRURITUS (arm began being extremely itchy) had resolved.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): In April 2021, Pregnancy test: Negative.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitant product use was not provided  by the reporter.  Treatment information was not provided.  Based on the information provided which includes a strong temporal association between the use of mRNA-1273 vaccine and onset of the reported events, excluding other etiologies causal relationship cannot be excluded; Sender's Comments: Based on the information provided which includes a strong temporal association between the use of mRNA-1273 vaccine and onset of the reported events, excluding other etiologies causal relationship cannot be excluded
The patient was given a 0.25ml Booster dose of Moderna Bivalent vaccine instead of 0.5ml, there is no sign & symptoms of adverse event observed during the time of administration and during the observation after vaccination
arm hurts; This is a spontaneous report received from a contactable reporter (Consumer or other non HCP).  A male patient received BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Solution for injection), administration date 29Jan2021 (Batch/Lot number: unknown) as dose number unknown, single for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. The following information was reported: PAIN IN EXTREMITY (non-serious) with onset 2021, outcome "recovering", described as "arm hurts".  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
Hospitalize Aug 4-14-2021. Acute myocarditis - and associated systolic Heart failure. Past Dx: Giant Cell ARteritis associated with polymyalgia rheumatica several yRs ago. MD Questioning associated myocarditis in Relation to COVID vaccines.
Information has been received from a Registered Nurse concerning a 21 year old female patient who "over 10 years ago" was vaccinated with two doses of VARIVAX (Merck). It was reported that on an unspecified date the patient had a chickenpox outbreak. It was reported that the patient still had negative titers to varicella. It was reported that the patient had not recovered at the time of the report. Additional information has been requested.
developed muscle aches post vaccine.  48 hours post vaccine had to leave shift early and was unable to work shift 72 hours post vaccine due to aches and fatigue
A few minutes after receiving the vaccine he felt like he was going to pass out. He became pale and diaphoretic, c/o having tunnel vision. He did not loose consciousness.
This spontaneous report as received from a Medical Assistant refers to 8 weeks old infant, gender not reported. On 19-NOV-2014, the patient was vaccinated with ROTATEQ, Lot # K011663, orally. It was reported that the administered vaccine was subjected to temperature excursion during storage. No adverse event was reported. This is one of the several reports from the same reporter. Additional information has been requested.
approximately 11 hours post vaccination, symptoms of headache and body aches. this was followed by shivering, weakness and a pounding heart. This continued for five to six hours. The shivering eased, leaving the pounding heart, terrible headache and body aches, especially in the neck and shoulders area. These remaining symptoms continued into day two.
I have developed a  red rash on my arm where I had the shot.  It showed up about a week after I had my shot.  It has lasted several days so far and is itchy and tender to to the touch.  It looks like it is getting better.
This spontaneous report as received from a licensed practical nurse refers to a patient of unknown age and gender. On an unknown date, the patient was vaccinated with an improperly dose of M-M-R II (lot # N023150 exp date 24-AUG-2019) (dose not reported) intramuscularly. Concomitant therapies included sterile diluent. There was a data logger issue. The temperature of excursion was 47 °F to 77 °F (47.3 °F) for a time frame of 5 minutes. No adverse effects were reported. This is one of several reports received from the same source. Sender's Comments: US-009507513-1809USA009046: US-009507513-1809USA009097: US-009507513-1809USA009098: US-009507513-1809USA009099.
After receiving the vaccine, I had body aches and felt tired for about 24 hours. On 11/24/2022 I started not feeling well with congestion, so I took a COVID-19 test and it was negative. On 11/25/2022, I took another COVID-19 home test and it was positive. I contacted my doctor and was given a prescription for PAXLOVID and they recommended that I take an expectorant. After three doses of PAXLOVID, I started feeling better.
pt recv vax; intermittent fever; low back & sl abd pain; frequent urination;
FINAL DIAGNOSIS:   1. Covid 19 2.  Acute hypoxemic respiratory failure secondary to COVID-19 3. A. Fib with chronic anticoagulation 4. BMI 44  5. HTN 6. HLD  7. OSA  9. Hypokalemia  10.  Asthma     REASON FOR HOSPITALIZATION AND ADMITTING DIAGNOSIS:   Shortness of Breath, Chest Pain, and Fever Hypokalemia  Acute respiratory failure with hypoxia (HCC)  Pneumonia due to COVID-19 virus    HOSPITAL COURSE:  Per HPI: Patient is a 64 y.o. year-old male, who presented with SOB.  Patient reports has been not feeling well for about a week.  Has previously received COVID-vaccine 2 years ago Johnson & Johnson.  States that he took a COVID test this past weekend and it was positive he started to feel much worse and presented to the emergency department.  In the ER he had an oxygen saturation in the mid 80s.  He does not normally wear oxygen but does have obstructive sleep apnea.  Denies any chest pains.   .Covid-19 Virus Infection Date of onset of symptoms: 3/28/2023 Symptoms present on admission: Hypoxemia/cough Date of covid positive test: 4/4/2023 Vaccination status: Received J&J Imaging:   Chest x-ray with new patchy density suggesting infiltrates within the perihilar aspect of the left mid chest and the right lung base/CT pulmonary artery study revealed no evidence of pulmonary embolism.  Moderate involvement of all lobes of the lung by patchy and groundglass airspace disease compatible with multifocal pneumonia such as viral COVID-pneumonia.  No pneumothorax or pleural effusion. Oxygen requirements on admission:   1 L nasal cannula Current oxygen requirements: Currently on room air at discharge Medical therapy: Completed remdesivir regimen/Decadron for 10 days Consultants following: Evaluated by infectious disease Anticipated special isolation end date: 5 days of quarantine/5 days a mask at discharge. Consultants following: Evaluated by infectious disease Anticipated special isolation end date: 5 days of quarantine/5 days a mask at discharge.    Potassium was 3.3 on day of discharge and this is likely secondary to patient's use of Lasix and hydrochlorothiazide.  I will keep him on potassium 20 mill equivalents daily until he follows with his family physician and they can continue to refill and check the patient's potassium level. His sodium is additionally 133 and this is likely secondary to Decadron use as well as diuretic use.   Blood cultures revealed no growth to date. Troponin was negative x2 and patient had recent heart cath.   Procalcitonin was normal this is likely not a bacterial pneumonia or infection at this time.   Patient reports he did not require any oxygen supplementation last night during sleep.  He reports that he does not need any assistance from care management at discharge.
The following symptoms iccured the day after I had the booster shot.  Sore throat Persistent cough Muscle aches Fatigue Then, on and off for about a week I had upper respiratory tightness and cough.   No fever at all.
there were no adverse effects from the administration; they administered MMR II that was expired to a patient; This spontaneous report was received from a medical assistant and refers to a patient of unknown age and gender. No information regarding the patient's concurrent condition, past medical history, concomitant medications and drug reactions or allergies was provided. On 14-DEC-2020, the patient was vaccinated with expired 0.5 ml dose of measles, mumps, and rubella (wistar ra 27-3) virus vaccine, live (M-M-R II) lot # R030807, expiration date 24-OCT-2020, albumin status recombinant human albumin (rHA) (route of administration was not reported) for prophylaxis. There were no adverse effects from the administration at this time.
got shingles after the vaccine/ suspected vaccination failure; shingles twice; This case was reported by a consumer via  interactive digital media and described the occurrence of suspected vaccination failure in a patient who received Herpes zoster (Shingles vaccine) for prophylaxis.   On an unknown date, the patient received Shingles vaccine. On an unknown date, unknown after receiving Shingles vaccine, the patient experienced vaccination failure (serious criteria GSK medically significant) and shingles. On an unknown date, the outcome of the vaccination failure and shingles were unknown.   It was unknown if the reporter considered the vaccination failure and shingles to be related to Shingles vaccine.  Additional details were reported as follows: The age at vaccination was not reported. The reporter knows someone who got the shingles twice after the vaccine. This case was considered to be a suspected vaccination failure case, as the details regarding completion of primary vaccination schedule, laboratory confirmation for shingles and time to onset were unknown. This case has been linked with the case US2021AMR176081, reported by same reporter.; Sender's Comments:  US-GLAXOSMITHKLINE-US2021AMR176081:same reporter (flu vaccine case)
SORE ARM; This spontaneous report received from a consumer via a company representative concerned a patient of unspecified age and sex. The patient's height, and weight were not reported. No past medical history or concurrent conditions were reported. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: Unknown) dose, start therapy date were not reported for prophylactic vaccination.  The batch number was not reported. Per procedure, no follow-up will be requested for this case. No concomitant medications were reported.  On an unspecified date, the patient experienced sore arm. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The outcome of sore arm was not reported. This report was non-serious.
After i received flu shot I had a bad headache.On 10-8-08  I woke up with chills and dizzines I called my doctors office  that morning I told the assisant my symptoms, and that I had a flu shot on 10-7-08. Nurse returned my call.I asked if it was okay to take some meclizine she asked what amount I  told her . I had some relief, the next morning 10-9-08 .I woke with the same sympotoms.
My son, had oral surgery 8/2/2019, 2 days after receiving the required meningitis vaccine at the student health clinic and received ketamine, fentanyl, and versed for anesthesia. He woke from surgery with a psychotic reaction and the following day 8/3/2019 and since has been blunted, flat affect, no emotions, child like, disinterested in surroundings, no memory of people or events prior to surgery. We are at Hospital referred by the on call pediatrician when we called Sunday 8/4/2019 to report no improvement in his condition. We have been admitted from ER and are undergoing multiple diagnostics and labs to determine the cause of the altered mental status. He is ambulatory and able to perform some tasks independently, but is not the same person he was prior to the vaccine or anesthesia. I am concerned there is an association between the ketamine and Menveo OR it is simply an adverse reaction to the Menveo alone. We admitted 8/4/2019 and are still here today 8/5/2019.
Within one hour of receiving 1st Hep B pt reported feeling light headed with nausea. Increased temperature 99.5-100 for 3 days after with extreme malaise.
got vaccine January of 2021 I have had the shingles 3 times/ suspected vaccination failure; had the shingles 3 times in my left eye; This case was reported by a consumer via interactive digital media and described the occurrence of suspected vaccination failure in a patient who received Herpes zoster (Shingles vaccine) for prophylaxis.   In January 2021, the patient received Shingles vaccine. On an unknown date, less than a year after receiving Shingles vaccine, the patient experienced vaccination failure (serious criteria GSK medically significant) and ophthalmic herpes zoster (serious criteria GSK medically significant). On an unknown date, the outcome of the vaccination failure and ophthalmic herpes zoster were unknown.   It was unknown if the reporter considered the vaccination failure and ophthalmic herpes zoster to be related to Shingles vaccine.  Additional details were provided as follows: The patient self-reported this case. The age at vaccination was not reported. The patient got the shingle vaccine in January 2021 and had the shingles 3 times in the left eye. The patient stated that the vaccine did not work. This case was considered as suspected vaccination failure since the details regarding completion of primary immunization schedule, time to onset and laboratory test confirming shingles were unknown at the time of reporting.